Vignola Mark J.

Average Profitability
85.92%
Insider Buys Quantity
5
Insider Buys Sum
$49,434.90
Insider Sells Quantity
1
Insider Sells Sum
$110,000.00

Insider Activity of Vignola Mark J.

According to the SEC Form 4 filings, Vignola Mark J., being in a position of

  1. Chief Financial Officer at Terns Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 5534 shares for $24,081, and sold 10000 shares for $110,000,
    over all time since 2022-05-31, has bought 23190 shares for $49,435, and sold 10000 shares for $110,000.

The largest purchase of all time was on 2024-05-31 and amounted to 4791 share of Terns Pharmaceuticals, Inc. for $21,272.

The largest sale of all time was on 2024-09-10 and amounted to 10000 shares of Terns Pharmaceuticals, Inc. for $110,000.

Biography of Vignola Mark J.

No biography is available at this moment.

2024-09-10SaleTerns Pharmaceuticals, Inc.
TERN
Chief Financial Officer
10,000
0.0139%
$11.00$110,000-29.96%
2024-05-31PurchaseTerns Pharmaceuticals, Inc.
TERN
Chief Financial Officer
4,791
0.0055%
$4.44$21,272+27.79%
2023-11-30PurchaseTerns Pharmaceuticals, Inc.
TERN
Chief Financial Officer
743
0.001%
$3.78$2,809+52.48%
2023-05-31PurchaseTerns Pharmaceuticals, Inc.
TERN
Chief Financial Officer
9,997
0.0019%
$1.41$14,096-43.54%
2022-11-30PurchaseTerns Pharmaceuticals, Inc.
TERN
3
<0.0001%
$1.41$4+7.66%
2022-05-31PurchaseTerns Pharmaceuticals, Inc.
TERN
Chief Financial Officer
7,656
0.0257%
$1.47$11,254+293.64%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.